Bioabsorbable Stents (BAS) - Medical Devices Pipeline Assessment, 2020

Bioabsorbable Stents (BAS) - Medical Devices Pipeline Assessment, 2020

Summary

The Medical Devices sector report, “Bioabsorbable Stents (BAS) - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Bioabsorbable Stents (BAS) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Bioabsorbable stents are also known as bioreabsorbable or biodegradable coronary stents. They are made from the material found in dissolvable sutures known as polylactic acid.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Bioabsorbable Stents (BAS) under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Bioabsorbable Stents (BAS) and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of Bioabsorbable Stents (BAS) under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Introduction

2.1 Bioabsorbable Stents (BAS) Overview

3 Products under Development

3.1 Bioabsorbable Stents (BAS) - Pipeline Products by Stage of Development
3.2 Bioabsorbable Stents (BAS) - Pipeline Products by Territory
3.3 Bioabsorbable Stents (BAS) - Pipeline Products by Regulatory Path
3.4 Bioabsorbable Stents (BAS) - Pipeline Products by Estimated Approval Date
3.5 Bioabsorbable Stents (BAS) - Ongoing Clinical Trials

4 Bioabsorbable Stents (BAS) - Pipeline Products under Development by Companies

4.1 Bioabsorbable Stents (BAS) Companies - Pipeline Products by Stage of Development
4.2 Bioabsorbable Stents (BAS) - Pipeline Products by Stage of Development

5 Bioabsorbable Stents (BAS) Companies and Product Overview

5.1 Abbott Vascular Inc Company Overview
5.2 Amaranth Medical Inc Company Overview
5.3 Arterius Ltd Company Overview
5.4 Biosensors International Group Ltd Company Overview
5.5 Biosten, LLC Company Overview
5.6 Biotronik AG Company Overview
5.7 Biotronik SE & Co KG Company Overview
5.8 Boston Scientific Corp Company Overview
5.9 Cardionovum GmbH Company Overview
5.10 Cordis Corp Company Overview
5.11 HangZhou HuaAn Biotechnology Co., Ltd. Company Overview
5.12 Icon Interventional Systems, Inc. Company Overview
5.13 Japan Stent Technology Co., Ltd. Company Overview
5.14 Kyoto Medical Planning Co Ltd Company Overview
5.15 Lifetech Scientific (Shenzhen) Co Ltd Company Overview
5.16 Manli Cardiology Ltd Company Overview
5.17 Micell Technologies Inc Company Overview
5.18 Michigan Technological University Company Overview
5.19 MicroPort Scientific Corp Company Overview
5.20 Minvasys SAS Company Overview
5.21 MIV Therapeutics Inc Company Overview
5.22 NanoCoeur, Inc. Company Overview
5.23 North Carolina State University Company Overview
5.24 Northwestern University Company Overview
5.25 OrbusNeich Company Overview
5.26 Pediastent LLC Company Overview
5.27 QualiMed Innovative Medizinprodukte GmbH Company Overview
5.28 REVA Medical Inc Company Overview
5.29 S3V Vascular Technologies Company Overview
5.30 Tepha Inc Company Overview
5.31 University of Alabama at Birmingham Company Overview
5.32 University of Florida Company Overview
5.33 University of Strathclyde Company Overview
5.34 VasoTech Inc. Company Overview
5.35 Xenogenics Corporation Company Overview

6 Bioabsorbable Stents (BAS)- Recent Developments

7 Appendix

7.1 Methodology
7.2 About the Publisher
7.3 Contact
7.4 Disclaimer

List of Tables

Table 1: Bioabsorbable Stents (BAS) - Pipeline Products by Stage of Development
Table 2: Bioabsorbable Stents (BAS) - Pipeline Products by Territory
Table 3: Bioabsorbable Stents (BAS) - Pipeline Products by Regulatory Path
Table 4: Bioabsorbable Stents (BAS) - Pipeline Products by Estimated Approval Date
Table 5: Bioabsorbable Stents (BAS) - Ongoing Clinical Trials
Table 6: Bioabsorbable Stents (BAS) Companies - Pipeline Products by Stage of Development
Table 7: Bioabsorbable Stents (BAS) - Pipeline Products by Stage of Development
Table 8: Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Second Generation Bioresorbable Vascular Scaffold - Product Status
Table 10: Second Generation Bioresorbable Vascular Scaffold - Product Description
Table 11: Amaranth Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 12: 80-micron MAGNITUDE Bioresorbable Scaffold - Product Status
Table 13: 80-micron MAGNITUDE Bioresorbable Scaffold - Product Description
Table 14: APTITUDE Sirolimus-Eluting Bioresorbable Scaffold - Product Status
Table 15: APTITUDE Sirolimus-Eluting Bioresorbable Scaffold - Product Description
Table 16: DEFIANCE Scaffold - Product Status
Table 17: DEFIANCE Scaffold - Product Description
Table 18: FORTITUDE Scaffold - Product Status
Table 19: FORTITUDE Scaffold - Product Description
Table 20: MAGNITUDE Sirolimus-Eluting Bioresorbable Scaffold - Product Status
Table 21: MAGNITUDE Sirolimus-Eluting Bioresorbable Scaffold - Product Description
Table 22: Second Generation FORTITUDE Scaffold - Product Status
Table 23: Second Generation FORTITUDE Scaffold - Product Description
Table 24: Amaranth Medical Inc - Ongoing Clinical Trials Overview
Table 25: FORTITUDE Scaffold - Amaranth Endovascular Study of a Drug-eluting Bioresorbable Coronary Scaffold
Table 26: FORTITUDE Scaffold - Restoring Endoluminal Narrowing Using Bioresorbable Scaffolds - European Trial
Table 27: APTITUDE Sirolimus-Eluting Bioresorbable Scaffold - Restoring Endoluminal Narrowing Using Bioresorbable Scaffolds - Extended Trial II
Table 28: MAGNITUDE Sirolimus-Eluting Bioresorbable Scaffold - Restoring Endoluminal Narrowing Using Bioresorbable Scaffolds - Extended Trial III
Table 29: Arterius Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 30: Arteriosorb Absorbable Drug-Eluting Scaffold - Product Status
Table 31: Arteriosorb Absorbable Drug-Eluting Scaffold - Product Description
Table 32: Biosensors International Group Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Sparrow Drug Eluting Stent System - Product Status
Table 34: Sparrow Drug Eluting Stent System - Product Description
Table 35: Biosten, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 36: Biodegradable Endovascular Implant - Product Status
Table 37: Biodegradable Endovascular Implant - Product Description
Table 38: Biotronik AG Pipeline Products & Ongoing Clinical Trials Overview
Table 39: DREAMS 3G System - Product Status
Table 40: DREAMS 3G System - Product Description
Table 41: Magmaris Bioresorbable Magnesium Scaffold - Product Status
Table 42: Magmaris Bioresorbable Magnesium Scaffold - Product Description
Table 43: Biotronik AG - Ongoing Clinical Trials Overview
Table 44: Magmaris Bioresorbable Magnesium Scaffold - A Sirolimus Eluting Bioresorbable Magnesium Stent for Treatment of Coronary Bifurcation Lesions: The BIFSORB Pilot Study II

List of Figures

Figure 1: Bioabsorbable Stents (BAS) - Pipeline Products by Stage of Development
Figure 2: Bioabsorbable Stents (BAS) - Pipeline Products by Territory
Figure 3: Bioabsorbable Stents (BAS) - Pipeline Products by Regulatory Path
Figure 4: Bioabsorbable Stents (BAS) - Pipeline Products by Estimated Approval Date
Figure 5: Bioabsorbable Stents (BAS) - Ongoing Clinical Trials